Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01814787 · ClinicalTrials.gov registry record · NA
Computer Automation for Diagnosis and Management of Childhood Type 2 Diabetes
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 1,369
- Enrollment target
NCT01814787: Completed NA study, sponsored by Indiana University.
NCT01814787 is a NA study that has completed, run by Indiana University. The registered enrollment target is 1,369 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01814787, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,369 participants
- Enrollment target
Study Summary
Increasing rates of type 2 diabetes among children and adolescents has considerable long-term implications not only for the affected individuals, but also for society and the health system as a whole. Pediatricians have unique and important opportunities to screen for type 2 diabetes and to promote lifestyle modification for those children identified with pre-diabetes; yet implementation of these practices within the pediatric primary care setting is far from ideal. The purpose of this study is to implement the ADA screening guidelines for type 2 diabetes and clinical management prompts within a pediatric primary care setting using a computer decision support system (CDSS) developed by the investigators research group - the Child Health Improvement through Computer Automation (CHICA) system. The investigators hypothesize that the coupling of CDSS with ADA guidelines will result in greater compliance with ADA recommended screening procedures as well as better clinical management of children identified as having pre-diabetes or type 2 diabetes.
Primary Outcome
Number of children (ages 10 and older) with documented risk factors for type 2 diabetes (\>85%BMI and 2 of 4 Risk Factors)
Interventions
- OTHER CHICA Type 2 Diabetes Module
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,369 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT01814787 record still lists
NCT01814787 is an interventional study that assigns participants to a tested intervention. Its 1,369 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which CHICA Type 2 Diabetes Module is the first listed.
NCT01814787 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01814787 about?
NCT01814787 is a clinical study titled "Computer Automation for Diagnosis and Management of Childhood Type 2 Diabetes". Increasing rates of type 2 diabetes among children and adolescents has considerable long-term implications not only for the affected individuals, but also for society and the health system as a whole. Pediatricians have unique and important opportunities to screen for type 2 diabetes and to promote ...
What is the current status of trial NCT01814787?
This trial is currently completed. It is a NA study. The enrollment target is 1,369 participants. The study started on 2013-10. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01814787?
The interventions under investigation include: CHICA Type 2 Diabetes Module (OTHER).
Who is sponsoring clinical trial NCT01814787?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01814787's enrollment target sits among peer trials
1,369 73rd of 2000 higher than 1,928 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07256392 · 1,370 participants · Phase 3
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
- NCT04489238 · 1,366 participants
Collection of Information to Better Understand Young Onset Colorectal Cancer
- NCT02677064 · 1,365 participants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
- NCT06651281 · 1,380 participants · Phase 3
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia